Efficacy News and Research

RSS
FLT-PET imaging can effectively detect mantle cell lymphoma

FLT-PET imaging can effectively detect mantle cell lymphoma

Autism Speaks announces 47 new ASD research grants

Autism Speaks announces 47 new ASD research grants

ACTF, Merck announce new HIV initiatives

ACTF, Merck announce new HIV initiatives

Impax submits IPX066 NDA to FDA for treatment of Parkinson's

Impax submits IPX066 NDA to FDA for treatment of Parkinson's

Denali Concrete Management initiates enrollment in CF101 phase 3 study for Dry Eye Syndrome

Denali Concrete Management initiates enrollment in CF101 phase 3 study for Dry Eye Syndrome

Researchers discover how spinning microparticles can direct neuron growth

Researchers discover how spinning microparticles can direct neuron growth

University of Western Ontario receives FDA approval to begin SAV001 HIV trial

University of Western Ontario receives FDA approval to begin SAV001 HIV trial

Vacc-4x nasal vaccine can effectively treat HIV

Vacc-4x nasal vaccine can effectively treat HIV

UCB initiates EXXELERATE study in rheumatoid arthritis

UCB initiates EXXELERATE study in rheumatoid arthritis

Takeda receives FDA approval for EDARBYCLOR to treat hypertension

Takeda receives FDA approval for EDARBYCLOR to treat hypertension

Amgen and Watson to collaborate on biosimilar anti-cancer drugs

Amgen and Watson to collaborate on biosimilar anti-cancer drugs

Hebrew University student wins Kaye Innovation Award for anti-cancer therapy

Hebrew University student wins Kaye Innovation Award for anti-cancer therapy

Top-line results from Genzyme's teriflunomide and Rebif Phase III comparison trial on RMS

Top-line results from Genzyme's teriflunomide and Rebif Phase III comparison trial on RMS

Top-line results from AstraZeneca and Targacept's TC-5214 Phase 3 study on MDD

Top-line results from AstraZeneca and Targacept's TC-5214 Phase 3 study on MDD

Impax commences IPX159 Phase IIb trial in Restless Legs Syndrome

Impax commences IPX159 Phase IIb trial in Restless Legs Syndrome

Phase I clinical study of Selexys SelG1 for sickle cell disease completed

Phase I clinical study of Selexys SelG1 for sickle cell disease completed

Fluoride supplements not found to be safe or effective

Fluoride supplements not found to be safe or effective

Newgen acquires novel oncology development programs from Kanion

Newgen acquires novel oncology development programs from Kanion

Alkermes commences ALKS 9070 phase 3 clinical trial for schizophrenia

Alkermes commences ALKS 9070 phase 3 clinical trial for schizophrenia

GSK initiates rhACE2 phase IIa study for Acute Lung Injury

GSK initiates rhACE2 phase IIa study for Acute Lung Injury

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.